Capsulomics, Inc.
Capsulomics, Inc., headquartered in the United States, is a pioneering company in the biotechnology sector, specialising in advanced drug delivery systems. Founded in 2018, Capsulomics has rapidly established itself as a leader in the development of innovative encapsulation technologies that enhance the bioavailability and efficacy of therapeutic compounds. The company focuses on creating unique, tailored solutions for pharmaceutical and nutraceutical applications, setting itself apart with its proprietary capsule designs and formulation expertise. With a commitment to research and development, Capsulomics has achieved significant milestones, including collaborations with major industry players and recognition for its contributions to drug delivery advancements. As it continues to expand its operational reach, Capsulomics remains dedicated to transforming the landscape of drug formulation and delivery.
DitchCarbon Score
How does Capsulomics, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Machinery and Equipment industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Capsulomics, Inc.'s score of 18 is lower than 65% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Capsulomics, Inc.'s reported carbon emissions
Capsulomics, Inc., headquartered in the US, currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures in kg CO2e. The company is a current subsidiary of Castle Biosciences, Inc., which may influence its climate commitments and reporting practices. While there are no documented reduction targets or climate pledges from Capsulomics, Inc., it is important to note that emissions data and sustainability initiatives may be inherited from its parent company. As such, stakeholders should consider the broader context of Castle Biosciences, Inc.'s climate strategies and performance, which may include industry-standard practices and commitments to carbon reduction. In summary, Capsulomics, Inc. has not disclosed specific emissions data or reduction targets, and its climate commitments may be aligned with those of its parent company, Castle Biosciences, Inc. Further information may be required to assess the company's overall environmental impact and sustainability initiatives.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Capsulomics, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
